Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-22-011755

EVP, Research & CSO sold 2,293 shares at $31.93 ($73,218)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-17 Sale : show line 1 in the form −2,293 $31.93 $73,218 105,407 D
Open-market sales · 2,293 sh · avg $31.93 · $73,218
Loading xslF345X03/doc4.xml…